Medicure Inc. (CVE:MPH – Get Free Report) shares crossed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of C$1.11 and traded as low as C$1.10. Medicure shares last traded at C$1.10, with a volume of 3,100 shares.
Medicure Stock Performance
The company has a market cap of C$11.48 million, a P/E ratio of -8.46 and a beta of 1.07. The company has a quick ratio of 1.29, a current ratio of 2.03 and a debt-to-equity ratio of 4.65. The business has a fifty day simple moving average of C$1.11 and a two-hundred day simple moving average of C$1.04.
Medicure Company Profile
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Recommended Stories
- Five stocks we like better than Medicure
- Want to Profit on the Downtrend? Downtrends, Explained.
- Eli Lilly Stock Soars on Trump Tariff Hopes and Pfizer Deal
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- 3 Exceptional Stocks to Build Long-Term Wealth
- How to find penny stocks to invest and trade
- Insider Sales Jump at Broadcom and CoreWeave: Red Flag Ahead?
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
